The significance of PAX6 in lung cancer and sarcoma
- Prosjektnummer
- SFP1054-12
- Ansvarlig person
- Lill-Tove Busund
- Institusjon
- Universitetet i Tromsø
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 2. Aetiology, 4. Detection and Diagnosis
Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
PLoS One 2014;9(11):e113039. Epub 2014 nov 17
PMID: 25401698
Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.
PLoS One 2014;9(9):e105038. Epub 2014 sep 16
PMID: 25225794
Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.
PLoS One 2014;9(7):e102559. Epub 2014 jul 16
PMID: 25029272
Discovery and verification of BRCA2 as a new target gene for PAX6.
to be submitted February 2016
PAX6 improves survival in node-positive non-small cell lung cancer patients.
Submitted to PLoS ONE, January 2016
- Yury Kiselev Postdoktorstipendiat
- Lill-Tove Busund Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord